stella
beta
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers — Stella
Home
/
Diabetic Foot Ulcer
/
View on ClinicalTrials.gov
Recruiting
Back to Diabetic Foot Ulcer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Site 001, Durham, North Carolina